Adjunct Photobiomodulation Therapy to conventional treatment was more effective than medical treatment alone*
A noticeable improvement of the clinical and functional
characteristics was remarked in patients.*
Symptoms and signs like, night dyspnea, cough,
effort dyspnea, morning symptoms, discharge, and in the lung exams the wheezing, and work absence showed a statistically significant difference (p<o.o5) after
adding LLLT.*
* Evaluation of the effect of low-level laser therapy (LLLT) in the treatment of asthma, added to conventional treatment (crossover, case-control clinical trial). WALT Conference - 2008
What is Photobiomodulation Therapy?
Photobiomodulation (PBM) therapy, (previously known as Low Level Laser Therapy or LLLT) is the application of light to tissues to reduce inflammation and improve healing. It works by increasing cellular energy (ATP) and reducing free radicals (oxidative stress). There are over 700 randomised controlled clinical trials published on PBM for a wide range of painful and non-healing applications including 32 controlled clinical trials on oral mucositis.
Light at specific wavelengths, can penetrate cells and activate the mitochondria, leading to increased cellular energy production, which is critical to cellular health, increased ATP energy levels and longevity.
The mitochondria organelles represent the batteries that fuel ALL the processes of our organs.
More cellular energy inside the cell = Optimum organ functionality
Case studies show that respiratory indices, radiological findings, oxygen requirements, and patient outcomes improved over several days and without need for a ventilator.
A 57-year-old African American man with severe COVID-19
4 once-daily PBMT sessions
Pre and Post RALE Assessment improved from 8 to 5
SpO2 increased 93-94% to 97-100%
O2 therapy decreased from 2-4 L/min to 1 L/min
_jp.jpg)
Source: Am J Case Rep 2020; 21:e926779
The Pneumonia Severity Index improved from Class V to Class II